Both of the grants are for the Bergen 4 Day treatment project, an RCT testing the non-inferiority, speed of recovery, and cost-effectiveness of Bergen 4-Day Treatment (B4DT) for obsessive compulsive disorder (OCD), compared to gold-standard CBT.
Sunny midsummer was great, but we are even happier that Max Sannemalm just joined our group!
Max is a licensed psychologist and will be joining us as the project coordinator for the randomized controlled non-inferiority trial study comparing the Bergen 4-Day Treatment (B4DT) to gold-standard CBT for OCD.
The Bergen 4-Day Treatment (B4DT) is a new concentrated treatment for OCD developed by Gerd Kvale and Bjarne Hansen from Bergen. In B4DT, patients receive ERP at a clinic during 4 consecutive days. The B4DT has shown to achieve remission in around 70% of patients when delivered in regular care in several uncontrolled treatment trials, and one randomized controlled trial (RCT) including a self-help group and a waitlist group. However, it has yet to be directly compared to gold-standard CBT.
The study will test the non-inferiority, speed of recovery, and cost-effectiveness of B4DT, compared to gold-standard.
To summarize: Exciting things ahead, and welcome to the group, Max!